Literature DB >> 12372004

Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones.

A Sahu1.   

Abstract

Leptin regulates food intake and body weight by acting primarily in the hypothalamus. In humans and rodents, obesity is associated with hyperleptinaemia, suggesting a possible state of leptin resistance. Thus, to begin to examine the mechanisms of leptin resistance, we developed a rat model in which chronic central leptin infusion results in the development of resistance to leptin's satiety action. Adult male rats were infused chronically into the lateral cerebroventricle with leptin (160 ng/h) or phosphate-buffered saline via Alzet pumps for 28 days, followed by artificial cerebrospinal fluid infusion for 3 weeks. After the initial decrease in food intake, rats developed resistance to the satiety action of leptin, and withdrawal of the chronic leptin infusion resulted in hyperphagia. During leptin infusion, body weight was gradually decreased to reach a nadir on day 12, and thereafter, body weight was sustained at a reduced level throughout the entire 28-day infusion, despite normalization in food intake. Body weight was mostly normalized by day 22 postleptin. Since neuropeptide Y (NPY) neurones are one of the targets of leptin signalling in the hypothalamus, we next examined whether the development of resistance to the satiety action of leptin was due to altered NPY gene expression. On day 3-4 of infusion, hypothalamic NPY mRNA levels, as determined by RNAse protection assay (RPA), were significantly decreased in leptin treated rats compared to controls. By contrast, on day 16 of infusion, NPY mRNA levels in the leptin treated group had returned to control levels. In situ hybridization study confirmed the results obtained with RPA and showed further that the effect of chronic leptin infusion on NPY mRNA levels was restricted to the rostral and middle parts of the arcuate nucleus. Overall, the finding that the action of continuous leptin exposure on NPY neurones was not sustained suggests that NPY neurones may be involved in the development of leptin resistance to the satiety action of leptin in the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372004     DOI: 10.1046/j.1365-2826.2002.00840.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  33 in total

1.  Phosphodiesterase-3B is expressed in proopiomelanocortin and neuropeptide Y neurons in the mouse hypothalamus.

Authors:  Maitrayee Sahu; David G Litvin; Abhiram Sahu
Journal:  Neurosci Lett       Date:  2011-10-06       Impact factor: 3.046

2.  Dose-related steady states of fat loss in long-term leptin-treated ob/ob mice: leptin resistance or desensitization versus counterregulatory signaling.

Authors:  Sandra Eiden; Eckhart Simon; Ingrid Schmidt
Journal:  J Comp Physiol B       Date:  2005-10-26       Impact factor: 2.200

3.  A role of phosphodiesterase-3B pathway in mediating leptin action on proopiomelanocortin and neurotensin neurons in the hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2010-05-13       Impact factor: 3.046

4.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

5.  Leptin receptor expressing neurons express phosphodiesterase-3B (PDE3B) and leptin induces STAT3 activation in PDE3B neurons in the mouse hypothalamus.

Authors:  Maitrayee Sahu; Abhiram Sahu
Journal:  Peptides       Date:  2015-08-20       Impact factor: 3.750

6.  Modeling energy intake and body weight effects of a long-acting amylin analogue.

Authors:  Annika Brings; Jens Markus Borghardt; Jolanta Skarbaliene; Tamara Baader-Pagler; Maria A Deryabina; Wolfgang Rist; Stefan Scheuerer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-23       Impact factor: 2.745

7.  Prieurianin Causes Weight Loss in Diet-Induced Obese Mice and Inhibits Adipogenesis in Cultured Preadipocytes.

Authors:  Ahmed Kablan; Rudel A Saunders; Maria Szkudlarek-Mikho; Andrew J B Chin; Raul M Bosio; Kazuyuki Fujii; Joseph Shapiro; Khew-Voon Chin
Journal:  J Diabetes Metab       Date:  2010-09-29

8.  Effects of chronic central leptin infusion on proopiomelanocortin and neurotensin gene expression in the rat hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2008-05-28       Impact factor: 3.046

9.  Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake.

Authors:  Su Gao; Kimberly P Kinzig; Susan Aja; Karen A Scott; Wendy Keung; Sandra Kelly; Ken Strynadka; Shigeru Chohnan; Wanli W Smith; Kellie L K Tamashiro; Ellen E Ladenheim; Gabriele V Ronnett; Yajun Tu; Morris J Birnbaum; Gary D Lopaschuk; Timothy H Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

10.  Evidence suggesting phosphodiesterase-3B regulation of NPY/AgRP gene expression in mHypoE-46 hypothalamic neurons.

Authors:  Prashanth Anamthathmakula; Maitrayee Sahu; Abhiram Sahu
Journal:  Neurosci Lett       Date:  2015-08-04       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.